글로벌 임상실험실 서비스 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

임상실험실 서비스 시장 분석

임상 검사 서비스 시장은 기술과 방법론의 발전으로 인해 상당한 성장을 이루었습니다. 주요 혁신에는 실험실 프로세스에 자동화와 인공 지능 (AI)을 도입하여 효율성과 정확성을 향상시키는 것이 포함됩니다. 자동화된 분석기와 AI 알고리즘은 샘플 처리 및 데이터 분석을 간소화하여 처리 시간을 줄이고 인적 오류를 최소화합니다.

또한 원격진료 및 원격 모니터링과 같은 디지털 건강 솔루션의 통합으로 실험실 서비스에 대한 접근성이 확대되었습니다. 이제 환자는 물리적 위치를 방문할 필요 없이 시기적절한 결과와 상담을 받을 수 있어 편의성과 치료 계획 준수가 촉진됩니다.

또한 분자 진단 및 차세대 시퀀싱 (NGS)의 발전으로 유전적 질환 및 감염성 질환의 탐지가 혁신되어 개인화된 의료 접근 방식이 탄생했습니다. 이러한 기술은 보다 정확한 진단을 가능하게 하고 표적 치료를 용이하게 합니다.

인구 고령화와 만성 질환의 증가로 인해 일상적이고 전문적인 검사에 대한 수요가 증가하면서 시장 성장이 더욱 촉진되었습니다. 의료가 계속 진화함에 따라 혁신적인 기술과 방법론을 활용하는 임상 실험실은 아마도 환자 치료와 결과를 개선하는 데 중요한 역할을 할 것입니다.

임상실험실 서비스 시장 규모

글로벌 임상 검사 서비스 시장 규모는 2023년에 2,968억 7,000만 달러로 평가되었으며, 2031년까지 5,294억 6,000만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 7.50%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

임상실험실 서비스 시장 동향

“Point-of-Care 검사에 대한 수요 증가”

임상 검사 서비스 시장은 원격 진료 서비스 의 증가로 인해 상당한 성장을 경험하고 있습니다 . 원격 진료는 환자가 의료 시설을 방문하지 않고도 검사 주문과 결과를 받을 수 있도록 원격 상담을 용이하게 합니다. 이러한 추세는 접근성과 편의성이 중요해진 COVID-19 팬데믹 동안 더욱 가속화되었습니다. 예를 들어 LabCorp와 Quest Diagnostics는 원격 진료 플랫폼을 확장하여 환자가 온라인으로 검사를 주문하고 디지털 커뮤니케이션을 통해 결과를 받을 수 있도록 했습니다. 원격 진료의 이러한 통합은 환자 참여를 개선할 뿐만 아니라 샘플 수집 및 처리를 간소화하여 검사실 효율성을 향상시킵니다. 원격 진료가 계속 발전함에 따라 임상 검사 서비스에 미치는 영향이 증가할 가능성이 큽니다.

보고서 범위 및 임상 검사 서비스 시장 세분화

Clinical Laboratory Services Market Definition

Clinical laboratory services encompass a range of diagnostic tests and analyses performed on biological samples, such as blood, urine, and tissue, to aid in disease diagnosis, treatment monitoring, and preventive health care. These services include hematology, microbiology, immunology, clinical chemistry, and molecular diagnostics. Advanced technologies, such as automation and molecular testing, enhance accuracy and efficiency. Clinical laboratories play a crucial role in the healthcare system by providing timely and reliable results that inform clinical decisions. With the rise of personalized medicine and telehealth, the demand for clinical laboratory services continues to grow, driving innovation and improving patient outcomes.

Clinical Laboratory Services Market Dynamics

Drivers

• Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases significantly drives the clinical laboratory services market. Conditions such as diabetes, cancer, and cardiovascular diseases are increasingly common, necessitating regular laboratory tests for early diagnosis and effective management. For instance, the International Diabetes Federation reported that approximately 537 million adults were living with diabetes in 2021, a number projected to rise to 643 million by 2030. This surge creates an urgent need for routine blood tests and monitoring, which clinical laboratories provide. In addition, the growing focus on preventive healthcare encourages patients to undergo regular screenings, further increasing the demand for laboratory services and expanding market opportunities.

• Rising Demand for Personalized Medicine

The rising demand for personalized medicine significantly drives the clinical laboratory services market. This approach tailors treatments based on individual genetic profiles and health conditions, necessitating specialized diagnostic tests. For instance, in April 2023, Flow Robotics announced the launch of ScanID, a revolutionary sample traceable device capable of performing both 1D and 2D scanning. This device can scan an entire row of sample tubes simultaneously, optimizing sample traceability and minimizing pre-analytical phase errors. By improving accuracy and efficiency in laboratory workflows, ScanID significantly enhances the clinical diagnosis and treatment process, ultimately benefiting patient outcomes through reliable and timely results.

Opportunities

• Emergence of New Pathogens and Infectious Diseases

The emergence of new pathogens and infectious diseases, notably COVID-19, has significantly increased the demand for rapid and accurate diagnostic testing. This situation has created opportunities for clinical laboratories to expand their testing capabilities, invest in advanced technologies, and enhance their service offerings. For instance, in August 2023, Redcliffe Labs partnered with Abbott India to introduce Clinical Decision Support (CDS), also known as AlinIQ. This innovative solution harnesses advanced technologies such as Big Data Engines and Artificial Intelligence (AI) to enhance clinical decision-making processes. The collaboration aims to empower healthcare professionals with valuable insights and analytics, enabling them to make informed decisions that improve patient care and streamline laboratory workflows in clinical settings.

• Increase in Laboratory Outsourcing

The rise in laboratory outsourcing presents a significant opportunity in the clinical laboratory services market. Healthcare providers increasingly seek specialized clinical laboratories to enhance operational efficiency and reduce costs. For instance, in November 2023, Atalan has significantly enhanced its network by incorporating TriCore, an independent, not-for-profit clinical laboratory. TriCore offers over 2,900 advanced laboratory tests, ensuring comprehensive services for healthcare professionals and their patients. Moreover, it provides essential analytics and research services, empowering healthcare and scientific organizations globally. This collaboration is expected to improve laboratory testing access and efficiency within the healthcare sector.

Restraints/Challenges

• High Operational Costs

High operational costs are a significant restraint in the clinical laboratory services market. The expenses related to state-of-the-art equipment, qualified personnel, and ongoing maintenance create financial burdens that can limit profitability. Smaller laboratories, in particular, often struggle to manage these high costs, which can lead to reduced service offerings and hinder their competitive edge. Furthermore, the need for continuous investment in technology to keep pace with advancements can strain budgets. This financial pressure makes it challenging for clinical laboratories to achieve sustainable growth, ultimately affecting their ability to operate effectively in a competitive market environment.   

• Shortages of Labour

The clinical laboratory industry faces significant challenges due to labour shortages, particularly among skilled professionals such as laboratory technicians and medical technologists. This scarcity of qualified personnel hampers service delivery, leading to delays in testing and processing results, which can ultimately affect patient care. The operational efficiency of laboratories is also compromised, as remaining staff may be overworked, resulting in increased error rates and diminished productivity. Furthermore, recruitment and training costs escalate in an attempt to fill vacancies, straining budgets and resources. These factors collectively hinder the growth of the clinical laboratory services market, limiting its ability to meet rising healthcare demands.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Clinical Laboratory Services Market Scope

The market is segmented on the basis of specialty, provider, application and service type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Specialty

• Clinical Chemistry Testing
  • Routine Chemistry Testing
  • Therapeutic Drug Monitoring Testing
  • Endocrinology Chemistry Testing
  • Specialized Chemistry Testing
  • Other Clinical Chemistry Testing
• Hematology Testing
• Microbiology Testing
  • Infectious Disease Testing
  • Transplant Diagnostic Testing
  • Other Microbiology Testing
• Immunology Testing
• Drugs of Abuse Testing
• Cytology Testing
• Genetic Testing

Provider

• Independent and Reference Laboratories
• Standalone
• Hospital-Based Laboratories
• Nursing and Physician Office-Based Laboratories

Application

• Drug Discovery Related Services
• Drug Development Related Services
• Bioanalytical, and Lab Chemistry Services
• Toxicology Testing Services
• Cell and Gene Therapy Related Services
• Preclinical and Clinical Trial Related Services
• Other

Service Type

• Routine Testing Services
• Esoteric Services
• Anatomic Pathology Services

Clinical Laboratory Services Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, specialty, provider, application and service type as referenced above.

The countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)

North America is expected to dominate the clinical laboratory services market, driven by an increasing elderly population and a high prevalence of chronic diseases. The region benefits from a well-established healthcare system and a robust reimbursement structure for clinical lab services. In addition, the growing need for effective treatment and patient care continues to fuel demand for clinical laboratory services, enhancing market growth.

Asia-Pacific (APAC) is expected to witness significant growth in the clinical laboratory services market during the forecast period. This growth is driven by an expansion of scientific research and increasing unmet medical needs. In addition, improvements in healthcare benefits, rising public awareness about health issues, and greater accessibility to high-quality medical care are anticipated to further boost the region's clinical laboratory services sector.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Clinical Laboratory Services Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Clinical Laboratory Services Market Leaders Operating in the Market Are:

• Abbott (U.S.)
• ARUP Laboratories (U.S.)
• OPKO Health, Inc. (U.S.)
• Bioscientia Healthcare GmbH (Germany)
• Charles River Laboratories (U.S.)
• NeoGenomics Laboratories (U.S.)
• Genoptix, Inc. (U.S.)
• Healthscope (Australia)
• The Laboratory Glassware Co. (U.S.)
• Laboratory Corporation of America Holdings (U.S.)
• Fresenius Medical Care AG & Co. KGaA (Germany)
• QIAGEN (Germany)
• Quest Diagnostics Incorporated (U.S.)
• Siemens Healthcare Private Limited (Germany)
• Tulip Diagnostics (P) Ltd. (India)
• Sonic Healthcare Limited (Australia)
• Merck KGaA (Germany)

Latest Developments in Clinical Laboratory Services Market

• In November 2023, Atalan has significantly enhanced its network by incorporating TriCore, an independent, not-for-profit clinical laboratory. TriCore offers over 2,900 advanced laboratory tests, ensuring comprehensive services for healthcare professionals and their patients. Moreover, it provides essential analytics and research services, empowering healthcare and scientific organizations globally. This collaboration is expected to improve laboratory testing access and efficiency within the healthcare sector
• In October 2023, in a groundbreaking collaboration, Froedtert Health, Wisconsin Diagnostic Laboratories (WDL), and HealthEco launched Atalan, a technology-based clinical partnership. This initiative aims to provide physicians and medical centers with unprecedented access to a carefully vetted network of the leading clinical laboratories in the United States. By leveraging technology, Atalan seeks to streamline laboratory services and improve patient outcomes through timely and accurate diagnostic testing
• In August 2023, Redcliffe Labs partnered with Abbott India to introduce Clinical Decision Support (CDS), also known as AlinIQ. This innovative solution harnesses advanced technologies such as Big Data Engines and Artificial Intelligence (AI) to enhance clinical decision-making processes. The collaboration aims to empower healthcare professionals with valuable insights and analytics, enabling them to make informed decisions that improve patient care and streamline laboratory workflows in clinical settings
• In August 2023, Laboratory Corporation of America Holdings (Labcorp) entered into a strategic agreement with Tufts Medicine to acquire its Outreach Laboratory Business. This acquisition aims to bolster Labcorp's diagnostic testing and laboratory services, enhancing its capabilities and service offerings. By integrating Tufts Medicine's established outreach services, Labcorp intends to expand its reach and provide comprehensive, high-quality laboratory services to healthcare providers and patients
• In July 2023, DiaCarta, Ltd. forged a partnership with Hopkins MedTech Lab Services and Hopkins MedTech Compliance to facilitate the development and validation of laboratory-developed tests in the U.S. This collaboration aims to streamline the testing process, ensuring regulatory compliance and enhancing the quality of diagnostic services. By combining expertise, the partnership is positioned to deliver innovative solutions that address the evolving needs of the healthcare landscape
• 2023년 4월, Flow Robotics는 1D 및 2D 스캐닝을 모두 수행할 수 있는 혁신적인 샘플 추적 장치인 ScanID를 출시한다고 발표했습니다. 이 장치는 샘플 튜브의 전체 행을 동시에 스캔하여 샘플 추적성을 최적화하고 사전 분석 단계 오류를 최소화할 수 있습니다. ScanID는 실험실 워크플로의 정확도와 효율성을 개선하여 임상 진단 및 치료 프로세스를 크게 향상시키고 궁극적으로 신뢰할 수 있고 시기적절한 결과를 통해 환자 결과에 도움이 됩니다.
• 2023년 2월, 네덜란드 바이오테크 기업인 Detact Diagnostics는 미국 Keene State College에 새로운 실험실을 설립한다고 발표했습니다. 이 이니셔티브에는 2년 임대 계약이 포함되어 있어 Detact는 연구 및 진단 목적으로 대학 시설을 활용할 수 있습니다. 새로운 실험실은 혁신적인 진단 솔루션을 개발하고 학술 기관과의 협업을 촉진하여 의료 및 바이오테크 분야의 발전을 촉진한다는 회사의 사명을 발전시키는 것을 목표로 합니다.

SKU-17264